HHMI
PODD icon

Howard Hughes Medical Institute’s Insulet PODD Stock Holding History

Howard Hughes Medical Institute’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15
Closed -$4.26K – 376
2025
Q4 		$4.26K Hold
15
– – ﹤0.01% 377
2025
Q3 		$4.63K Hold
15
– – ﹤0.01% 359
2025
Q2 		$4.71K Buy
+15
New +$4.33K ﹤0.01% 342

Other funds holding PODD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Howard Hughes Medical Institute's PODD Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Insulet (PODD) in Q1 2026, closing a stake of 15 shares — an estimated $4.26K sold.

Howard Hughes Medical Institute first reported a position in PODD in Q2 2025 and held it in 3 quarters. The position peaked at $4.71K in Q2 2025. 785 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Insulet position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 15 Insulet shares in Q1 2026, an estimated $4.26K.
  • Howard Hughes Medical Institute first reported a position in Insulet in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Insulet position peaked at $4.71K in Q2 2025.
  • 785 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.